New genomics database increases research collaboration
An international research team launched a new open-source database – multiplex assays of variant effect (MAVEs) – as a public repository for large-scale measurements of sequence variant impact, designed for interoperability with applications to interpret these datasets. Details of the database are presented in the November 3 issue of Genome Biology.
An international research team launched a new open-source database – multiplex assays of variant effect (MAVEs) – as a public repository for large-scale measurements of sequence variant impact, designed for interoperability with applications to interpret these datasets. Details of the database are presented in the November 3 issue of Genome Biology.
AACR launches $36M genomics project with big pharma
The American Association for Cancer Research (AACR) is launching a $36 million research project in collaboration with big pharma to expand its Genomics Evidence Neoplasia Information Exchange (GENIE) clinical genomics databank.
The American Association for Cancer Research (AACR) is launching a $36 million research project in collaboration with big pharma to expand its Genomics Evidence Neoplasia Information Exchange (GENIE) clinical genomics databank.
NIH Invests $100 million in cures for sickle cell disease and HIV
The National Institutes of Health (HIH) announced that it plans to invest at least $100 million over the next four years towards developing affordable, gene-based cures for sickle cell disease (SCD) and HIV. The NIH aims to make these cures globally available, including in low-resource settings. The NIH is partnering with the Bill & Melinda Gates Foundation who will contribute $100 million.
The National Institutes of Health (HIH) announced that it plans to invest at least $100 million over the next four years towards developing affordable, gene-based cures for sickle cell disease (SCD) and HIV. The NIH aims to make these cures globally available, including in low-resource settings. The NIH is partnering with the Bill & Melinda Gates Foundation who will contribute $100 million.
Thermo Fisher announces new temperature stable media
On October 21, Thermo Fisher released a new cell culture media for biological researchers that remains stable at room temperature. The new product is called Gibco BenchStable Media, which offers an alternative for researchers looking to work without cold storage but that also saves energy and is shipped with sustainable packaging. Discuss
On October 21, Thermo Fisher released a new cell culture media for biological researchers that remains stable at room temperature. The new product is called Gibco BenchStable Media, which offers an alternative for researchers looking to work without cold storage but that also saves energy and is shipped with sustainable packaging. Discuss
$7 million NIH grant awarded for testing advancing sequencing tools
The National Center for Advancing Translational Sciences (NCATS) and the All of Us Research Program (both part of the NIH) announced a $7 million award to HudsonAlpha Institute for Biotechnology, Huntsville, Alabama to evaluate the use of leading-edge DNA sequencing technologies. The funds will hopefully improve diagnosis and treatment in a variety of diseases.
The National Center for Advancing Translational Sciences (NCATS) and the All of Us Research Program (both part of the NIH) announced a $7 million award to HudsonAlpha Institute for Biotechnology, Huntsville, Alabama to evaluate the use of leading-edge DNA sequencing technologies. The funds will hopefully improve diagnosis and treatment in a variety of diseases.
New reference genome helps understand diversity
Houston, TX – At the American Society of Human Genetics 2019 Annual Meeting scientists shared results from the new human reference genome project. The new sequences improve the utility of the human reference genome, a touchstone resource for modern genetics and genomics research. There is a need to improve the reference to better capture genetic diversity among different human populations.
Houston, TX – At the American Society of Human Genetics 2019 Annual Meeting scientists shared results from the new human reference genome project. The new sequences improve the utility of the human reference genome, a touchstone resource for modern genetics and genomics research. There is a need to improve the reference to better capture genetic diversity among different human populations.
NIH research shows racial disparities in grant awards
According to a new study by National Institutes of Health (NIH) scientists, published in Science Advances on October 9, research topic preference accounts for more than 20% of a persistent funding gap for black scientists applying for National Institutes of Health research project (R01) grants compared to white scientists. Each step of the application submission and review processes for R01 applications were examined between 2011-2015.
According to a new study by National Institutes of Health (NIH) scientists, published in Science Advances on October 9, research topic preference accounts for more than 20% of a persistent funding gap for black scientists applying for National Institutes of Health research project (R01) grants compared to white scientists. Each step of the application submission and review processes for R01 applications were examined between 2011-2015.
UC Davis awarded grant for Oral CRISPR treatment
UC Davis researchers have just been awarded $1.5 million from the National Institutes of Health (NIH) to start work of a novel approach to deliver CRISPR genome-editing machinery to gut cells in a way that will fix genes responsible for a rare form of familial cancer. The research team hopes that this work will lead to new treatments for diseases of the gut.
UC Davis researchers have just been awarded $1.5 million from the National Institutes of Health (NIH) to start work of a novel approach to deliver CRISPR genome-editing machinery to gut cells in a way that will fix genes responsible for a rare form of familial cancer. The research team hopes that this work will lead to new treatments for diseases of the gut.
EMBO & ASAPbio unite with new preprints platform
EMBO Press and ASAPbio announced on September 30, 2019, that they have partnered to create Review Commons, a brand-new platform to facilitate preprint peer review prior to manuscript submission. The site will be launched in December 2019.
EMBO Press and ASAPbio announced on September 30, 2019, that they have partnered to create Review Commons, a brand-new platform to facilitate preprint peer review prior to manuscript submission. The site will be launched in December 2019.
FDA restructures to support new drug development
The U.S. Food and Drug Administration announced on September 26, 2019 that the Center for Drug Evaluation and Research (CDER) reorganization has been approved. The reorganization will take place within certain offices of New Drugs Regulatory Program (NDRP).
The U.S. Food and Drug Administration announced on September 26, 2019 that the Center for Drug Evaluation and Research (CDER) reorganization has been approved. The reorganization will take place within certain offices of New Drugs Regulatory Program (NDRP).